1. CTNI-44. A PHASE 0 'TRIGGER' TRIAL OF PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS. (14th November 2022) Authors: Sanai, Nader; Chang, Yu-Wei; Jiang, Jun; Molloy, Jennifer; Montgomery, Chelsea; Harmon, Jocelyn; Hong, Amy; Wanebo, John; Kennedy, William; Garcia, Michael; Barani, Igor; Yoo, Wonsuk; Tovmasyan, Artak; Tien, An-Chi; Li, Jing; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-54. A PHASE 0/1 'TRIGGER' TRIAL OF RIBOCICLIB PLUS EVEROLIMUS IN RECURRENT HIGH-GRADE GLIOMA. (14th November 2022) Authors: Sanai, Nader; Tien, An-Chi; Jiang, Jun; Chang, Yu-Wei; Montgomery, Chelsea; DeSantis, Anita; Fujita, Yoko; Kim, Seongho; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗